CHRISTMAS OFFERS: Guaranteed placements bundles available
Each week, we will be rolling out two special visibility packages designed to boost your campaign reach and impact. These packages will be available to purchase up until the end of 2025.

biomaterials Newsroom

Korvaa consortium unveils world-first concept shoe formed from three revolutionary biomaterial technologies

Groundbreaking footwear design unites mycelium, bacterial nanocellulose, and polyhydroxyalkanoates (PHAs), signalling a new era of nature-inspired manufacturing. Concept shoe debuts at the Future Fabrics Expo, London (24-25 June 2025), inviting industry-wide collaboration in sustainable innovation. London, UK. June 24th 2025  – The Korvaa Consortium, a pioneering collaboration of biomaterial innovators,

Read More »
June 24, 2025

4D Biomaterials Ltd secures ISO 13485 Certification

NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI).  This globally recognised quality standard for medical device manufacturing

Read More »
April 3, 2025

4D Medicine Launches New Corporate Website to Showcase Next-Generation Bioabsorbable Polymer and Medical Device Solutions

NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk. The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the

Read More »
March 11, 2025

Modern Synthesis secures $5.5M to commercialise groundbreaking biomaterial technology

Leading climate investors are backing Modern Synthesis’ biomaterial technology to reduce emissions and plastic pollution from fashion, footwear, and automotive industries. LONDON, UK. February 5th, 2025 – Modern Synthesis, a biotechnology company pioneering the development of microbially-derived biomaterials, today announces the successful close of a $5.5 million funding round. The

Read More »
February 5, 2025

Join the 10,000+ businesses that already use PR Fire today!